Back to Search Start Over

Transfer of Fresh versus Frozen Embryos in Ovulatory Women.

Authors :
Shi Y
Sun Y
Hao C
Zhang H
Wei D
Zhang Y
Zhu Y
Deng X
Qi X
Li H
Ma X
Ren H
Wang Y
Zhang D
Wang B
Liu F
Wu Q
Wang Z
Bai H
Li Y
Zhou Y
Sun M
Liu H
Li J
Zhang L
Chen X
Zhang S
Sun X
Legro RS
Chen ZJ
Source :
The New England journal of medicine [N Engl J Med] 2018 Jan 11; Vol. 378 (2), pp. 126-136.
Publication Year :
2018

Abstract

Background: Elective frozen-embryo transfer has been shown to result in a higher live-birth rate than fresh-embryo transfer among anovulatory women with the polycystic ovary syndrome. It is uncertain whether frozen-embryo transfer increases live-birth rates among ovulatory women with infertility.<br />Methods: In this multicenter, randomized trial, we randomly assigned 2157 women who were undergoing their first in vitro fertilization cycle to undergo either fresh-embryo transfer or embryo cryopreservation followed by frozen-embryo transfer. Up to two cleavage-stage embryos were transferred in each participant. The primary outcome was a live birth after the first embryo transfer.<br />Results: The live-birth rate did not differ significantly between the frozen-embryo group and the fresh-embryo group (48.7% and 50.2%, respectively; relative risk, 0.97; 95% confidence interval [CI], 0.89 to 1.06; P=0.50). There were also no significant between-group differences in the rates of implantation, clinical pregnancy, overall pregnancy loss, and ongoing pregnancy. Frozen-embryo transfer resulted in a significantly lower risk of the ovarian hyperstimulation syndrome than fresh-embryo transfer (0.6% vs. 2.0%; relative risk, 0.32; 95% CI, 0.14 to 0.74; P=0.005). The risks of obstetrical and neonatal complications and other adverse outcomes did not differ significantly between the two groups.<br />Conclusions: The live-birth rate did not differ significantly between fresh-embryo transfer and frozen-embryo transfer among ovulatory women with infertility, but frozen-embryo transfer resulted in a lower risk of the ovarian hyperstimulation syndrome. (Funded by the National Key Research and Development Program of China and the National Natural Science Foundation of China; Chinese Clinical Trial Registry number, ChiCTR-IOR-14005406 .).

Details

Language :
English
ISSN :
1533-4406
Volume :
378
Issue :
2
Database :
MEDLINE
Journal :
The New England journal of medicine
Publication Type :
Academic Journal
Accession number :
29320646
Full Text :
https://doi.org/10.1056/NEJMoa1705334